ClinicalTrials.gg
CompletedNCT06655909Updated May 22, 2025

Serum Ferritin Concentration in Kenyan Women and Their Preschool Children at Which the Body Begins to Upregulate Iron Absorption From the Diet

An interventional study of consumption of maize porridge containing stable iron isotope in Healthy Volunteer, Mothers and Preschool Children, sponsored by Isabelle Herter-Aeberli. Completed at 1 site in Kenya. Open to female participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-22.

Sponsored by Isabelle Herter-Aeberli · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
275
Allocation
Non-randomized
Ages
18 Years to 30 Years
Sex
Female
01

Study summary

Using standardized methods, the investigators will perform stable iron isotope absorption studies in young Kenyan women and their preschool children (2-5y of age) with varying iron status to measure iron absorption from maize meal containing labeled ferrous sulfate. Using these data, this study aim is to define the ferritin in these young women and children at which the body senses iron depletion and begins to upregulate iron absorption from the diet; this approach could provide a functionally defined threshold of iron deficiency in Sub-Saharan African women and children.

Read the detailed description

In this experimental study in southern Kenya, the investigators will take a baseline venous blood sample to measure iron and inflammation biomarkers in generally healthy young women (n=125) and in their preschool children. The investigators will then administer, after an overnight fast, a standardized test meal porridge made from refined maize and bottled water containing the stable iron isotope 57Fe. Fourteen days later, the investigators will take a second venous blood sample for determination of erythrocyte incorporation of the 57Fe to measure iron absorption from the labeled test meal.

02

Conditions studied

  • Healthy Volunteer
  • Mothers
  • Preschool Children

Keywords

  • iron absorption
  • serum ferritin
  • maize porridge
03

In context

Lead sponsor

Isabelle Herter-Aeberli is the lead sponsor of 13 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • \< 75 kg
  • between 17 - 27.5 kg/m2
  • No acute illness (self-reported)
  • No metabolic or gastrointestinal disorders (self-reported)
  • No use of medication affecting iron absorption or metabolism during the study
  • No intake of mineral/vitamin supplements 2 weeks prior to the first study visit and during study
  • Mother of a preschool age child (2-5 years)
  • Child has normal Z-scores for WAZ, HAZ and WHZ (-3 - +3)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
275 participants (actual)

Study arms

  • Other
    mothers

    healthy volunteers

    Other: consumption of maize porridge containing stable iron isotope

  • Other
    preschool children

    healthy volunteers

    Other: consumption of maize porridge containing stable iron isotope

Interventions

  • Otherconsumption of maize porridge containing stable iron isotope

    consumption of maize porridge containing stable iron isotope

06

What researchers measure

Primary outcomes

  1. Fractional iron absorption

    Erythrocyte iron incorporation

    Time frame: Study day 14

Secondary outcomes

  1. Serum ferritin

    Serum ferritin concentration

    Time frame: Study day 1

  2. soluble transferrin receptor

    soluble transferrin receptor concentration in serum

    Time frame: Study day 1

  3. C-reactive protein

    C-reactive protein concentration in serum

    Time frame: Study day 1

  4. alpha(1)-acid-glycoprotein

    alpha(1)-acid-glycoprotein concentration in serum

    Time frame: Study day 1

07

Study locations

1 site
  • ETH/JKUAT Research Station
    Msambweni, Kenya
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2024 to primary completion in Nov 2024, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 22, 2024
First posted
Oct 24, 2024
StartActual
Oct 23, 2024
Primary completionActual
Nov 13, 2024
CompletionActual
Nov 13, 2024
Last update
May 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06655909
Lead sponsor
Isabelle Herter-Aeberli
Collaborators
Jomo Kenyatta University of Agriculture and Technology
Responsible party
Isabelle Herter-Aeberli (PhD, Swiss Federal Institute of Technology) — Sponsor-investigator
First posted
Oct 24, 2024
Start date
Oct 23, 2024
Primary completion
Nov 13, 2024
Completion
Nov 13, 2024
Last update
May 22, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion